Pre-Doctoral Fellowship in Health Outcome Disparities supports doctoral students studying disproportionate disease burdens or healthcare disparities to improve underserved U.S. populations’ health.
Funder: American Foundation for Pharmaceutical Education
Due Dates: November 18, 2026 (Call for applications) | December 11, 2026 (Part 1) | January 29, 2027 (Part 2)
Funding Amounts: $10,000 stipend for one year, September 1–August 31
Summary: Supports pre-doctoral research on diseases disproportionately affecting underserved U.S. populations or reducing healthcare disparities and improving health outcomes.
Key Information: Applicants must be U.S. citizens or permanent residents enrolled full-time in an eligible pharmaceutical sciences Ph.D. program.
The American Foundation for Pharmaceutical Education (AFPE) offers this fellowship to recognize a pre-doctoral student whose research addresses the health needs of underserved populations in the United States. It supports two related directions: studying a disease that disproportionately affects an underserved population, or reducing healthcare disparities and improving health outcomes. Examples include sickle-cell anemia, asthma, HIV/AIDS, maternal and infant mortality, and access to medication.
The fellowship shares the eligibility requirements and application process of AFPE’s Pre-Doctoral Research Fellowship in Pharmaceutical Sciences. That broader program supports high-performing students with the potential to become scientists and leaders in industry, academia, and government or nonprofit sectors, with the goal of improving patient and public health. Applicants not selected for the Health Outcome Disparities fellowship are automatically considered for a Pre-Doctoral Award in Pharmaceutical Sciences.